Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins - PubMed (original) (raw)

Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins

H L Hsu et al. Mol Cell Biol. 1991 Jun.

Abstract

Almost 30% of patients with T-cell acute lymphoblastic leukemia (T-ALL) bear structural alterations of tal-1, a presumptive proto-oncogene that encodes sequences homologous to the helix-loop-helix (HLH) DNA-binding and dimerization domain. Analysis of the tal-1 gene product reveals that its HLH domain mediates protein-protein interactions with either of the ubiquitously expressed HLH proteins E47 and E12. The resultant tal-1/E47 and tal-1/E12 heterodimers specifically recognize the E-box DNA sequence motif found in eucaryotic transcriptional enhancers. Hence, the tal-1 protein shares biochemical properties with other tissue-specific HLH proteins that control cell type determination during myogenesis (e.g., MyoD1) and neurogenesis (e.g., achaete-scute). The data suggest that HLH heterodimers involving tal-1 may function in vivo as transcriptional regulatory factors that influence cell type determination during hematopoietic development.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Gene. 1988 Jul 15;67(1):31-40 - PubMed
    1. EMBO J. 1990 Mar;9(3):821-31 - PubMed
    1. Cell. 1989 Feb 24;56(4):607-17 - PubMed
    1. Cell. 1989 Mar 10;56(5):777-83 - PubMed
    1. EMBO J. 1989 Mar;8(3):701-9 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources